financetom
Business
financetom
/
Business
/
Oklo Q2 Loss Widens
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oklo Q2 Loss Widens
Aug 13, 2024 2:38 PM

05:08 PM EDT, 08/13/2024 (MT Newswires) -- Oklo ( OKLO ) reported a Q2 net loss late Tuesday of $5.17 per Class A share, compared with a $0.06 loss a year earlier.

Oklo ( OKLO ) is developing fast fission power plants to provide clean energy.

Price: 7.50, Change: +0.08, Percent Change: +1.08

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pfizer, BioNTech Covid Vaccine Receives Approval in UK
Pfizer, BioNTech Covid Vaccine Receives Approval in UK
Jul 24, 2024
01:59 PM EDT, 07/24/2024 (MT Newswires) -- Pfizer ( PFE ) and BioNTech's (BNTX) COVID-19 vaccine was approved by the UK health regulator on Wednesday. Comirnaty JN.1 will offer protection against the JN.1 COVID-19 subvariant, according to a statement from the Medicines and Healthcare products Regulatory Agency. Comirnaty JN.1 was previously approved by the European Medicines Agency. Price: 29.81, Change:...
--BlackRock Maintains Quarterly Dividend at $5.10 Per Share; Payable Sept. 23 to Shareholders on Sept. 9
--BlackRock Maintains Quarterly Dividend at $5.10 Per Share; Payable Sept. 23 to Shareholders on Sept. 9
Jul 24, 2024
01:58 PM EDT, 07/24/2024 (MT Newswires) -- Price: 837.77, Change: -6.92, Percent Change: -0.82 ...
Clean Energy Fuels Begins Construction of Renewable Natural Gas Facility in Texas
Clean Energy Fuels Begins Construction of Renewable Natural Gas Facility in Texas
Jul 24, 2024
01:57 PM EDT, 07/24/2024 (MT Newswires) -- Clean Energy Fuels ( CLNE ) said Wednesday it has started construction on a facility for producing renewable natural gas at South Fork Dairy in Dimmitt, Texas. The project cost is estimated to be around $85 million, and it's anticipated to be finished by 2025, the company said. The facility is expected to...
Sophia Genetics Says OncoHelix to Use MSK-Access With Sophia DDM
Sophia Genetics Says OncoHelix to Use MSK-Access With Sophia DDM
Jul 24, 2024
01:55 PM EDT, 07/24/2024 (MT Newswires) -- Sophia Genetics ( SOPH ) said Wednesday that OncoHelix, a research and precision diagnostics laboratory in Canada, will implement liquid biopsy MSK-Access powered with Sophia DDM beginning this summer. MSK-Access with SOPHiA DDM is a decentralized ctDNA test developed by Memorial Sloan Kettering Cancer Center, according to the company. Sophia said that OncoHelix...
Copyright 2023-2026 - www.financetom.com All Rights Reserved